The American Diabetes Association’s (ADA) Scientific Sessions are the world’s largest, most prominent meetings on diabetes. It provides healthcare professionals an opportunity to learn about the most significant advances in diabetes research, treatment, and care.
Don’t miss our panel of international experts discuss some of the key research presented in San Francisco and what it means for healthcare practitioners and their patients.
Start
June 26, 2019 - 8:30 pm
End
June 26, 2019 - 9:30 pm
Address
Online View map
International Experts Discuss Key Learnings from the ADA’s 79th Scientific Sessions
Don’t miss our panel of international experts discuss some of the key research presented in San Francisco and what it means for healthcare practitioners and their patients.
By attending this event, you’ll get:
- Accredited content (certificates for live viewing only)
- Expert discussion of the latest findings from the ADA’s 79th Scientific Sessions and how this will impact practice
- Live Q&A with diabetes experts from around the world
- FREE Post-event access to practical resources
Don’t miss out on this free online event! Join us Wednesday, June 26, 2019 at 20:30 CET for this interactive discussion!
Key topics for discussion
- Comparison of oral Semaglutide with other classes of glucose-lowering therapy (PIONEER)
- Dulaglutide and major cardiovascular events (REWIND)
- Linagliptin versus Glimepiride in cardiovascular outcomes (CAROLINA)
- Dapagliflozin and cardiovascular outcomes (DECLARE)
Panel of international experts in diabetes
- Dr. Peter Lin, MD, CCFP (moderator)
- Dr. David C.W. Lau, MD, PhD, FRCPC
- Dr. Thomas Round, MD
- Dr. David Strain, MB, ChB, BSc (Hons) MD, FRCP
Don’t miss out on this free online event! Join us Wednesday, June 26 2019 at 20:30 CET for this interactive discussion!
Register now